Liquiritigenin (Rt: 3.034), is reported to ameliorate renal inflammation through suppression of AQP4/NF-kB/IkBa signaling as well as NLRP3 inflammasome in hyperuricemic rats, thus showing anthyperuricemic effects (49). Here, NFKBIA is linked to inflammatory response.